Real-world treatment patterns and outcomes of patients with small cell lung cancer progressing after 2 lines of therapy

Anna D. Coutinho,Manan Shah,Orsolya E. Lunacsek,Michael Eaddy,Joanne P. Willey

Lung Cancer（2019）

引用 16|浏览6

暂无评分

摘要

•Due to limited 3rd-line therapies patients often received best supportive care only.•Patients left untreated (best supportive care only) live less than 1 month.•Median overall survival is less than 5 months for patients who did receive therapy.•Current therapies yield limited benefit thus new therapeutic options are needed.

查看译文

关键词

3L,4L,5L,BSC,CI,DoR,ECOG,EMR,ES,FDA,ICD,IRB,NCCN,ORR,OS,PFS,PS,RECIST,SCLC,SD,US

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要